Clinical trial
A Study to Evaluate the Effectiveness of Aranesp® for Cancer Patients With…
NCT00117039 · Amgen, Industry · Completed
Key facts
| NCT number | NCT00117039 |
|---|---|
| Title | A Study to Evaluate the Effectiveness of Aranesp® for Cancer Patients With Anemia |
| Official title | SYNCHRONICITY: A Study to Evaluate the Effectiveness of Aranesp® at 300 Mcg Q3W on Clinical Outcomes in Cancer Patients With Anemia Due to Chemotherapy |
| Lead sponsor | Amgen, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Anemia, Neoplasms |
| Intervention type | Drug |
| Interventions | Aranesp® |
| Enrollment | 1,500 |
| Start date | Jan 1, 2004 |
| Completion | Apr 1, 2005 |
| First posted | Jul 4, 2005 |
| Last update posted | Oct 15, 2008 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: